TVARDI THERAPEUTICS, INC. Capital Expenditures Incurred but Not yet Paid
TVARDI THERAPEUTICS, INC. (TVRD) reported Capital Expenditures Incurred but Not yet Paid of $19.00 thousand for the 6-month period ending 2024-06-30, per its 10-Q filed 2024-08-14.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2025-05-13
- TVARDI THERAPEUTICS, INC. capital expenditures incurred but not yet paid for the quarter ending 2024-06-30 was -$192.00K.
- TVARDI THERAPEUTICS, INC. capital expenditures incurred but not yet paid for the quarter ending 2024-03-31 was $211.00K.
- TVARDI THERAPEUTICS, INC. capital expenditures incurred but not yet paid for the quarter ending 2023-12-31 was -$29.00K.
- TVARDI THERAPEUTICS, INC. capital expenditures incurred but not yet paid for fiscal 2023 was $778.00K.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|
| 2024-06-30 | -$192.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $19.00K 10-Q · filed 2024-08-14 | -$10.00K derived: sum of 3 quarters · filed 2025-05-13 | |
| 2024-03-31 | $211.00K 10-Q · filed 2025-05-13 | $182.00K derived: sum of 2 quarters · filed 2025-05-13 | ||
| 2023-12-31 | -$29.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $778.00K 10-K · filed 2025-03-11 | ||
| 2023-09-30 | $807.00K 10-Q · filed 2024-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |